Sign in | Join | Help

All Tags » Options » (V) (

RSS)

Browse Blog Posts by Tags

Showing related tags and posts for the Investor Blogs application. See all tags in the site

Issue: 3/19/2008

The Playbook 100 CELG @ $57.68 (Celgene) develops therapies to treat cancer and immune-inflammatory related diseases. Revenues have increased between 43% and 76% during each of the last four quarters. Earnings have increased between 72% and 136% during the same time frame and are expected to grow 43...

Posted to The Stock Playbook by Dave Dispennette on 03-19-2008
Filed under: Filed under: IPO's, New Issues, Options, The Playbook 100, ETF's, (FXI), (CELG), (V)

Page 1 of 1 (1 items)

© 2003-2008 InvestorsInsight Publishing, Inc.

Investor Blogs

John Mauldin's Thoughts From The Frontline
John Mauldin's Outside The Box
Forecasts & Trends by Gary D. Halbert
Daily Pfennig by Chuck Butler
Musing on the Markets by Vinny Catalano
AIA Advocate for Absolute Returns

Richard Schwartz's Principles of the Stock Market
The Options Report with Ken Trester
The Stock Playbook with Dave Dispennette
The Room with David Galland
Retirement Watch by Bob Carlson
Growth Report by Ian Wyatt
Steve Cook's Strategic Stock Investments

Useful Links

Partners
Advertise
Privacy Policy
Legal Statement
Who Is Online
Help